EDENT1FI: European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception

Project: Research

Project Details

AcronymEDENT1FI
StatusActive
Effective start/end date1/11/202331/10/2028

Collaborative partners

  • King's College London
  • Cardiff University
  • Critical Path Institute (C-Path) Amsterdam
  • DiabetOmics, Inc
  • Digostics Limited
  • HANNOVERSCHE KINDERHEILANSTALT
  • Helmholtz Zentrum München GmbH
  • ImCyse SA
  • IRCCS Ospedale San Raffaele
  • JDRF Juvenile Diabetes Research Foundation
  • KU Leuven (lead)
  • Leona M & Harry B Helmsley Charitable Trust
  • Medical University of Graz
  • Medical University of Warsaw
  • Medtronic Bakken Research Center B.V.
  • Medtronic International Trading Sàrl
  • Novo Nordisk A/S
  • Provention Bio Inc.
  • REGION HOVEDSTADEN
  • Sanofi-Aventis Deutschland GmbH
  • Sanofi US Services Inc.
  • Sanofi-Aventis Recherche & Development
  • TU Dresden
  • University Hospital in Motol
  • University of Birmingham
  • University of Oxford
  • University of Siena
  • University of Silesia in Katowice
  • University of Tampere
  • University of Turku
  • Associacao Protectora Dos Diabeticos De Portugal
  • European Diabetes Forum AISBL

Funding

  • TSB Technology Strategy Board: £145,567.95